Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tumor vessels were persistently compressed by solid stress from tumor interstitial matrix, resulting in limited vessel perfusion and oxygen concentrations. Collagen within matrix participated in transmitting the solid stress to tumor vessels and limiting drug delivery. PURPOSE: The objective of this study was to identify whether gold nanoparticles (AuNPs) were able to decompress colorectal cancer vessels and enhance vessel perfusion as well as drug delivery in colorectal cancer. METHODS: Colorectal cancer xenograft mice were treated with AuNPs or normal saline for 14 days. The cancer stromal collagen I level, cancer vessel perfusion, hypoxia of tumor were tested by histological examination. We also test the solid stress in the two groups. Furtherly, the effect and the drug delivery of combined using AuNPs and cisplatin were tested. The effect and the underlying mechanism of AuNPs on SW620 cells were tested by CCK8, flow cytometry, Western-blot and atomic force microscope. RESULTS: AuNPs were able to decrease the density of colorectal cancer associated fibroblasts (CAFs), to reduce the production of tumor stromal collagen I, and to diminish the expression of profibrotic signals, including CTGF, TGF-β1 as well as VEGF in vivo and vitro via Akt signaling pathway. Consequently, AuNPs could alleviate solid stress in tumors, subsequently leading to enhanced vessel perfusion. Therefore, cisplatin as well as oxygen delivery to tumors were improved by AuNPs, which reduced hypoxia while sensitizing therapy of cisplatin in colorectal cancer model. CONCLUSION: AuNPs were effective agents in enhancing cisplatin delivery and potentiating inhibiting tumor growth by decompressing colorectal cancer vessels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, gold nanoparticles have been used to effectively deliver various anti-CRC therapies to tumor cells, including chemotherapy drugs and anti-EGFR inhibitors, resulting in enhanced anticancer drug efficacy [110,111,112].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 1×
“CAFs are typically iden-tified by α -SMA, a myocyte marker 23,24 and other agents, such as fibroblast-specific protein (FSP-1).”
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024 · cited 1×
“31,32 In consideration of the collagen density in breast cancers and fibrosis in hepatic cancer as independent risk factors, dense ECM and fibrosis are likely to be involved in tumor initiation.”
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Mammographic Density and the Risk and Detection of Breast Cancer
Boyd, N. F., Guo, H., Martin, L. J., Sun, L., Stone, J., Fishell, E., Jong, R. A., Hislop, G., Chiarelli, A., Minkin, S., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062790 · Cited by 2,478
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589 · cited 1×
“38,39 In spite of the impediment in larger drug distribution by steric interplays with collagen, the delivery of smaller chemotherapy agents is not directly blocked, 40 which, however, is indirectly hindered by vessel compression.”
Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma
Conklin, M. W., Eickhoff, J. C., Riching, K. M., Pehlke, C. A., Eliceiri, K. W., Provenzano, P. P., Friedl, A., & Keely, P. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.076 · Cited by 1,285
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248
Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
Stylianopoulos, T., Martin, J. D., Chauhan, V. P., Jain, S. R., Diop-Frimpong, B., Bardeesy, N., Smith, B. L., Ferrone, C. R., Hornicek, F. J., Boucher, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213353109 · Cited by 943
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
Goetz, J. G., Minguet, S., Navarro-Lérida, I., Lazcano, J. J., Samaniego, R., Calvo, E., Tello, M., Osteso-Ibáñez, T., Pellinen, T., Echarri, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.040 · Cited by 720
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
Whatcott, C. J., Diep, C. H., Jiang, P., Watanabe, A., LoBello, J., Sima, C., Hostetter, G., Shepard, H. M., Von Hoff, D. D., & Han, H. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1051 · Cited by 645
Cell Mechanics: Integrating Cell Responses to Mechanical Stimuli
Janmey, P. A., & McCulloch, C. A. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.151927 · Cited by 630
Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 603
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114300 · Cited by 597
Stylianopoulos, T., Martin, J. D., Snuderl, M., Mpekris, F., Jain, S. R., & Jain, R. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4521 · Cited by 477
Mori, T., Kawara, S., Shinozaki, M., Hayashi, N., Kakinuma, T., Igarashi, A., Takigawa, M., Nakanishi, T., & Takehara, K. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199910)181:1<153::aid-jcp16>3.0.co;2-k · Cited by 468
Antiangiogenic Properties of Gold Nanoparticles
Mukherjee, P., Bhattacharya, R., Wang, P., Wang, L., Basu, S., Nagy, J. A., Atala, A., Mukhopadhyay, D., & Soker, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2482 · Cited by 468
Adya, R., Tan, B. K., Punn, A., Chen, J., & Randeva, H. S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm111 · Cited by 437
Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
Augsten, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00062 · Cited by 427
Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis†
Elsharkawy, A. M., & Mann, D. A. (2007) · Hepatology · doi:10.1002/hep.21802 · Cited by 396
Arnida, Malugin, A., & Ghandehari, H. (2010) · Journal of Applied Toxicology · doi:10.1002/jat.1486 · Cited by 378
Sorensen, A. G., Emblem, K. E., Polaskova, P., Jennings, D., Kim, H., Ancukiewicz, M., Wang, M., Wen, P. Y., Ivy, P., Batchelor, T. T., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2464 · Cited by 295
Suzuma, K., Naruse, K., Suzuma, I., Takahara, N., Ueki, K., Aiello, L. P., & King, G. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006509200 · Cited by 240
Arvizo, R. R., Rana, S., Miranda, O. R., Bhattacharya, R., Rotello, V. M., & Mukherjee, P. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.01.011 · Cited by 229
Optical volume and mass measurements show that mammalian cells swell during mitosis
Zlotek-Zlotkiewicz, E., Monnier, S., Cappello, G., Le Berre, M., & Piel, M. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201505056 · Cited by 226
Automated quantification of aligned collagen for human breast carcinoma prognosis
Bredfeldt, J. S., Liu, Y., Conklin, M. W., Keely, P. J., Mackie, T. R., & Eliceiri, K. W. (2014) · Journal of Pathology Informatics · doi:10.4103/2153-3539.139707 · Cited by 214
Siveen, K. S., Prabhu, K., Krishnankutty, R., Kuttikrishnan, S., Tsakou, M., Alali, F. Q., Dermime, S., Mohammad, R. M., & Uddin, S. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666170105124038 · Cited by 209
Role of TGFβ in regulation of the tumor microenvironment and drug delivery (Review)
PAPAGEORGIS, P., & STYLIANOPOULOS, T. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2816 · Cited by 206
Hanley, C. J., Noble, F., Ward, M., Bullock, M., Drifka, C., Mellone, M., Manousopoulou, A., Johnston, H. E., Hayden, A., Thirdborough, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6740 · Cited by 205
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem2093oia1 · Cited by 170
Loh, S., Mistry, P., Kelland, L., Abel, G., & Harrap, K. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.419 · Cited by 167
Angiogenesis in rheumatoid arthritis.
Maruotti, N., Cantatore, F. P., Crivellato, E., Vacca, A., & Ribatti, D. (2006) · PubMed · doi:10.14670/hh-21.557 · Cited by 162
Towards Effective Photothermal/Photodynamic Treatment Using Plasmonic Gold Nanoparticles
Bucharskaya, A. B., Maslyakova, G. N., Terentyuk, G. S., Yakunin, A. N., Avetisyan, Y. A., Bibikova, O., Tuchina, E. S., Khlebtsov, B. N., Khlebtsov, N. G., & Tuchin, V. V. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081295 · Cited by 145
Tumor mechanics and metabolic dysfunction
Tung, J. C., Barnes, J. M., Desai, S. R., Sistrunk, C., Conklin, M. W., Schedin, P., Eliceiri, K. W., Keely, P. J., Seewaldt, V. L., & Weaver, V. M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.11.020 · Cited by 124
Li, W., Zhao, X., Du, B., Li, X., Liu, S., Yang, X.-Y., Ding, H., Yang, W., Pan, F., Wu, X., et al. (2016) · Scientific Reports · doi:10.1038/srep30619 · Cited by 116
Self-citationSurvival of women with breast cancer in Europe: Variation with age, year of diagnosis and country
Sant, M., Capocaccia, R., Verdecchia, A., Estève, J., Gatta, G., Micheli, A., Coleman, M. P., Berrino, F., & The EUROCARE Working Group (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980831)77:5<720::aid-ijc10>3.0.co;2-5 · Cited by 97
Pan, Y., Wu, Q., Li, Q., Cai, J., & Du, B. (2014) · BioMed Research International · doi:10.1155/2014/418624 · Cited by 97
Self-citationLi, W., Li, X., Liu, S., Yang, W., Pan, F., Yang, X.-Y., Du, B., Qin, L., & Pan, Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s128802 · Cited by 77
Self-citationLi, Z., Bork, J. P., Krueger, B., Patsenker, E., Schulze-Krebs, A., Hahn, E. G., & Schuppan, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.005 · Cited by 71
Behr, T. M., Memtsoudis, S. G., Sharkey, R. M., Blumenthal, R. D., Dunn, R. M., Gratz, S., Wieland, E., Nebendahl, K., Schmidberger, H., Goldenberg, D. M., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980831)77:5<787::aid-ijc19>3.0.co;2-z · Cited by 66
A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer
Pathak, R., Wen, R. M., Kolishetti, N., & Dhar, S. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0445 · Cited by 63
Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow
Danese, S. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32810c8de3 · Cited by 57
Antibacterial efficacy of acridine derivatives conjugated with gold nanoparticles
Mitra, P., Chakraborty, P. K., Saha, P., Ray, P., & Basu, S. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.051 · Cited by 54
Gold Nanoparticles Induce Nanostructural Reorganization of VEGFR2 to Repress Angiogenesis
Pan, Y., Ding, H., Qin, L., Zhao, X., Cai, J., & Du, B. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1678 · Cited by 49
Self-citationLiu, W. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i41.6489 · Cited by 34
Pan, Y., Wu, Q., Liu, R., Shao, M., Pi, J., Zhao, X., & Qin, L. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.11.045 · Cited by 33
Self-citationFibroblast heterogeneity in the cancer wound
Tuveson, D. A., Elyada, E., & Öhlund, D. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.2063oia128 · Cited by 16
VEGF inhibition beyond tumour progression
Grothey, A. F. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70516-8 · Cited by 10
Cited by
Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives
Khursheed, R., Dua, K., Vishwas, S., Gulati, M., Jha, N. K., Aldhafeeri, G. M., Alanazi, F. G., Goh, B. H., Gupta, G., Paudel, K. R., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112951 · Cited by 286
Fibroblasts in the Tumor Microenvironment
Truffi, M., Sorrentino, L., & Corsi, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_2 · Cited by 154
Engineered nanoparticles for imaging and drug delivery in colorectal cancer
Pavitra, E., Dariya, B., Srivani, G., Kang, S.-M., Alam, A., Sudhir, P.-R., Kamal, M. A., Raju, G. S. R., Han, Y.-K., Lakkakula, B. V. K. S., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.017 · Cited by 102
Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer
Liu, X., Wang, J., Ashby, C. R., Zeng, L., Fan, Y., & Chen, Z. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.030 · Cited by 144
Nanotechnology in Colorectal Cancer for Precision Diagnosis and Therapy
Brar, B., Ranjan, K., Palria, A., Kumar, R., Ghosh, M., Sihag, S., & Minakshi, P. (2021) · Frontiers in Nanotechnology · doi:10.3389/fnano.2021.699266 · Cited by 115
Metadata
- Authors
- Zhao, X., Pan, J., Li, W., Yang, W., Qin, L., & Pan, Y.
- Affiliations
- First Affiliated Hospital of Jinan University (CN)
- Corresponding author
- Pan, Yunlong
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2018-10
- Volume
- Volume 13
- Pages
- 6207-6221
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC6188185
- OpenAlex
- W2895615845
- Cited by
- 75
- References
- 52
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 14 · 2023: 9 · 2022: 13 · 2021: 12 · 2020: 10 · 2019: 4
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Natural Science Foundation of China (81472849)
- Jinan University
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- gold nanoparticles, cisplatin, colorectal cancer, solid stress, tumor hypoxia, tumor stroma, type I collagen, cancer-associated fibroblasts, connective tissue growth factor, TGF-β1, vascular endothelial growth factor, Akt signaling, chemosensitization, drug delivery
- MeSH terms
- Cancer-Associated Fibroblasts, Animals, Cell Count, Cisplatin, Colonic Neoplasms, Endocytosis, Female, Fibrosis, Gold, Humans, Mice, Inbred BALB C, Mice, Nude, Oxygen, Perfusion, Colorectal Neoplasms, Signal Transduction, Cell Hypoxia, Cytokines, Drug Delivery Systems, Treatment Outcome, Stromal Cells, Collagen Type I, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, Metal Nanoparticles, Transforming Growth Factor beta1, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.